摘要
目的:探讨综合治疗重症支原体肺炎体会。方法:将50例重症支原体肺炎患儿随机分为两组,治疗组25例,对照组25例。治疗组在常规治疗基础上,早期应用甲基强的松龙及丙种球蛋白联合治疗。对照组常规治疗。结果:治疗组在治疗疗程上显著短于对照组,且治愈率高、差异显著(P<0.05)。结论:支原体直接损伤及感染后免疫反应是重症支原体肺炎感染主要发病机制。采用甲基泼尼松龙及大剂量丙种球蛋白可明显缩短病程。
Objective：To investigate the comprehensive treatment of severe Mycoplasma pneumoniae pneumonia treatment. Methods： 50 cases of severe mycoplasma pneumonia patients were randomly divided into two groups, 25 cases in the treatment group, 25 cases in the control group. The treatment group on the basis of routine treatment, early use of methylprednisolone and immunoglobulin combined treatment. The control group received routine treatment. Results ： the treatment group in the course of treatment was significantly shorter than that in the control group, and the cure rate is high, significant difference （ P 〈 0. 05 ）. Conclusion ： Mycoplasma direct injury and infection after severe mycoplasma pneumonia infection immune response is the main pathogenesis. With methyl prednisolone and large dose of gamma globulin can significantly shorten the course of disease.
